Literature DB >> 28257824

27-Hydroxycholesterol induces invasion and migration of breast cancer cells by increasing MMP9 and generating EMT through activation of STAT-3.

Zhaoxia Shen1, Dongmei Zhu1, Jiao Liu1, Juan Chen1, Yun Liu1, Chunyan Hu1, Zhong Li2, Yuan Li3.   

Abstract

Breast carcinoma plays a vital role in the reasons of global women's death. ER-related invasion and migration play an important part in the development and prognosis of breast cancer. Here, we found that 27-Hydroxycholesterol (27HC) could induce epithelial-mesenchymal transition (EMT) and increase the expression of the matrix metalloproteinase 9 (MMP9) at mRNA level and the active form. Meanwhile, interestingly, we found 27HC activated signal transducer and activator of transcription 3 (STAT-3) in ER positive cells except activation of ER signaling. Furthermore, inhibition of STAT-3 by siRNA attenuated the 27HC-induced improvement of MMP9 and decreased the invasion and migration ability in MCF7 and T47D cells. In addition, 27HC could also promote MMP9, vimentin and active STAT-3 in the ER negative cells MDA-MB-231. All these results not only raise a mechanism whereby 27HC enhances the invasion and metastasis, but also is helpful to realize 27HC as a potential endogenous detrimental factor in breast tumor patients.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  27-Hydroxycholesterol; Breast cancer; Epithelial-mesenchymal transition; Invasion and migration; Matrix metalloproteinase 9; Signal transducer and activator of transcription 3

Mesh:

Substances:

Year:  2017        PMID: 28257824     DOI: 10.1016/j.etap.2017.02.001

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  20 in total

Review 1.  Diabetes, Obesity, and Breast Cancer.

Authors:  Chifei Kang; Derek LeRoith; Emily J Gallagher
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

Review 2.  27-Hydroxycholesterol, an endogenous selective estrogen receptor modulator.

Authors:  Sisi He; Erik R Nelson
Journal:  Maturitas       Date:  2017-07-31       Impact factor: 4.342

3.  Recruitment of monocytes and epigenetic silencing of intratumoral CYP7B1 primarily contribute to the accumulation of 27-hydroxycholesterol in breast cancer.

Authors:  Shui-Zhen Shi; Eun-Joon Lee; Ying-Jiong Lin; Lu Chen; Huai-Yu Zheng; Xiang-Qin He; Jing-Yi Peng; Satish K Noonepalle; Austin Y Shull; Felix C Pei; Li-Bin Deng; Xiao-Li Tian; Ke-Yu Deng; Huidong Shi; Hong-Bo Xin
Journal:  Am J Cancer Res       Date:  2019-10-01       Impact factor: 6.166

4.  Natriuretic peptide receptor a promotes breast cancer development by upregulating MMP9.

Authors:  Jingkun Qu; Xixi Zhao; Xu Liu; Yuchen Sun; Jizhao Wang; Lin Liu; Jiansheng Wang; Jia Zhang
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

5.  Relationship between matrix metalloproteinase-9 and some clinicopathological prognostic factors of breast carcinoma.

Authors:  Fereshteh Mohammadizadeh; Mahsa Bagherian-Dehkordia
Journal:  Am J Clin Exp Immunol       Date:  2021-02-15

6.  The 14-3-3η/GSK-3β/β-catenin complex regulates EndMT induced by 27-hydroxycholesterol in HUVECs and promotes the migration of breast cancer cells.

Authors:  Jing Zhen; Kailin Jiao; Keke Yang; Maoxuan Wu; Qian Zhou; Bingmo Yang; Wei Xiao; Chunyan Hu; Ming Zhou; Zhong Li
Journal:  Cell Biol Toxicol       Date:  2020-11-01       Impact factor: 6.691

7.  Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor.

Authors:  Jia Gu; Neng Zhu; Hong-Fang Li; Tan-Jun Zhao; Chan-Juan Zhang; Duan-Fang Liao; Li Qin
Journal:  Cell Oncol (Dordr)       Date:  2022-07-22       Impact factor: 7.051

8.  27-Hydroxycholesterol is a specific factor in the neoplastic microenvironment of HCC that causes MDR via GRP75 regulation of the redox balance and metabolic reprogramming.

Authors:  Ming Jin; Ye Yang; Yi Dai; Rong Cai; Liunan Wu; Yuwen Jiao; Zhan Zhang; Haojun Yang; Yan Zhou; Liming Tang; Lei Li; Yuan Li
Journal:  Cell Biol Toxicol       Date:  2021-04-20       Impact factor: 6.691

Review 9.  Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy.

Authors:  Isabella Giacomini; Federico Gianfanti; Maria Andrea Desbats; Genny Orso; Massimiliano Berretta; Tommaso Prayer-Galetti; Eugenio Ragazzi; Veronica Cocetta
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

Review 10.  Our evolving understanding of how 27-hydroxycholesterol influences cancer.

Authors:  Liqian Ma; Wonhwa Cho; Erik R Nelson
Journal:  Biochem Pharmacol       Date:  2021-05-24       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.